Clinical care and other categories posters: Hormone replacement therapy

Clinical care and other categories posters: Hormone replacement therapy P344Clinical effectiveness of testosterone replacement therapy in hypogonadal men with Type 2 diabetes: A systematic review and meta‐analysisM ABDALLA1, J James2 and A Dunkley21Health Science, University of Leicester, Leicester, UK, 2Leicester Diabetes Centre, Leicester General Hospital, Leicester, UKAims: We aimed to conduct a systematic review and meta‐analysis of randomised controlled trials (RCTs) to determine the clinical effectiveness of testosterone replacement therapy (TRT) in hypogonadal men with Type 2 diabetes.Methods: A systematic search of six online databases was performed to identify studies reporting RCTs utilising testosterone interventions for hypogonadal men with Type 2 diabetes. A total of 313 articles were identified and reviewed independently and assessed for risk of bias using Cochrane risk of bias tool. Eight eligible studies met the inclusion criteria were included in the met‐analysis.Results: TRT significantly reduced HbA1c% (MD = −0.94; 95% confidence interval (CI) −1.53, −0.35, p = 0.002), fasting plasma glucose levels (MD = −1.91; 95% CI (−3.21, −0.61, p = 0.004) and fasting serum insulin (MD = −2.70; 95% CI (−3.60, −1.79, p = 0.01)). There were no significant effects on body mass index (BMI) (MD = −11; 95% CI (−0.48, 0.26, p = 0.57)), homeostatic model assessment index of insulin resistance (HOMA‐IR) (MD = −0.97; 95% CI (−2.45, 0.52, p = 0.20)), parameters of lipid profiles (MD = −0.07; 95% CI (−0.58, 0.43, p = 0.78)) and blood pressure (MD = 0.18; 95% CI (−0.38, 0.73, p = 0.53)).Conclusion: Our findings suggest TRT significantly improved parameters of glycaemic control and decreased levels of fasting serum insulin in hypogonadal men with Type 2 diabetes with no other significant clinical effects. Many previous studies have claimed that TRT have significant effects on BMI, lipid profiles and HOMA‐IR, but our study demonstrates the opposite. Therefore, the results of this study might help change the clinical practice. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Diabetic Medicine Wiley

Clinical care and other categories posters: Hormone replacement therapy

Free
1 page

Loading next page...
1 Page
 
/lp/wiley/clinical-care-and-other-categories-posters-hormone-replacement-therapy-ydPBZVWELe
Publisher
Wiley Subscription Services, Inc., A Wiley Company
Copyright
Diabetic Medicine © 2018 Diabetes UK
ISSN
0742-3071
eISSN
1464-5491
D.O.I.
10.1111/dme.37_13571
Publisher site
See Article on Publisher Site

Abstract

P344Clinical effectiveness of testosterone replacement therapy in hypogonadal men with Type 2 diabetes: A systematic review and meta‐analysisM ABDALLA1, J James2 and A Dunkley21Health Science, University of Leicester, Leicester, UK, 2Leicester Diabetes Centre, Leicester General Hospital, Leicester, UKAims: We aimed to conduct a systematic review and meta‐analysis of randomised controlled trials (RCTs) to determine the clinical effectiveness of testosterone replacement therapy (TRT) in hypogonadal men with Type 2 diabetes.Methods: A systematic search of six online databases was performed to identify studies reporting RCTs utilising testosterone interventions for hypogonadal men with Type 2 diabetes. A total of 313 articles were identified and reviewed independently and assessed for risk of bias using Cochrane risk of bias tool. Eight eligible studies met the inclusion criteria were included in the met‐analysis.Results: TRT significantly reduced HbA1c% (MD = −0.94; 95% confidence interval (CI) −1.53, −0.35, p = 0.002), fasting plasma glucose levels (MD = −1.91; 95% CI (−3.21, −0.61, p = 0.004) and fasting serum insulin (MD = −2.70; 95% CI (−3.60, −1.79, p = 0.01)). There were no significant effects on body mass index (BMI) (MD = −11; 95% CI (−0.48, 0.26, p = 0.57)), homeostatic model assessment index of insulin resistance (HOMA‐IR) (MD = −0.97; 95% CI (−2.45, 0.52, p = 0.20)), parameters of lipid profiles (MD = −0.07; 95% CI (−0.58, 0.43, p = 0.78)) and blood pressure (MD = 0.18; 95% CI (−0.38, 0.73, p = 0.53)).Conclusion: Our findings suggest TRT significantly improved parameters of glycaemic control and decreased levels of fasting serum insulin in hypogonadal men with Type 2 diabetes with no other significant clinical effects. Many previous studies have claimed that TRT have significant effects on BMI, lipid profiles and HOMA‐IR, but our study demonstrates the opposite. Therefore, the results of this study might help change the clinical practice.

Journal

Diabetic MedicineWiley

Published: Jan 1, 2018

There are no references for this article.

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 12 million articles from more than
10,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Unlimited reading

Read as many articles as you need. Full articles with original layout, charts and figures. Read online, from anywhere.

Stay up to date

Keep up with your field with Personalized Recommendations and Follow Journals to get automatic updates.

Organize your research

It’s easy to organize your research with our built-in tools.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

Monthly Plan

  • Read unlimited articles
  • Personalized recommendations
  • No expiration
  • Print 20 pages per month
  • 20% off on PDF purchases
  • Organize your research
  • Get updates on your journals and topic searches

$49/month

Start Free Trial

14-day Free Trial

Best Deal — 39% off

Annual Plan

  • All the features of the Professional Plan, but for 39% off!
  • Billed annually
  • No expiration
  • For the normal price of 10 articles elsewhere, you get one full year of unlimited access to articles.

$588

$360/year

billed annually
Start Free Trial

14-day Free Trial